Turning scientific discoveries into better treatments...

The University of Queensland Diamantina Institute (UQDI) is a modern research facility where clinical and basic science converge in the translational research of cancer, immunology and genomic medicine.

The Institute is host to over 300 researchers, students and support staff. It lays claim to global, world-changing discoveries such as the world’s first cervical cancer vaccine.

Based at the Translational Research Institute beside the Princess Alexandra Hospital, UQDI has strong clinical interactions and world-class facilities that enable researchers to be at the forefront of their fields. UQDI's position within the TRI allows for a much greater collaborative research environment, allowing our researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases including a variety of cancers, osteoporosis, arthritis and other autoimmune diseases.

About UQDI section


In 2007, the University of Queensland Diamantina Institute was established as the sixth research institute of The University of Queensland. The Institute was formed through the amalgamat...

Our Staff


As a research institute at The University of Queensland, the UQDI is recognised as a collaborative member of a non-profit academic institution.

UQDI Development Board

The University of Queensland Diamantina Institute (UQDI) is deeply grateful for the support and participation of its volunteer Development Board.   The Board plays a vital role in helping to elevate the Institute&rsquo...

Foreword from the Director

Over 150 years ago, Lady Diamantina Bowen established here in Brisbane one of the first hospitals in Australia, from which evolved the Princess Alexandra Hospital and our Diamantina Institute - all sharing the goal of improving health.

The Translational Research Institute

UQDI has been part of the Translational Research Institute since late 2012. TRI is an Australian-first and will see Australia play a leading role in int...
Go to top